RSV Vaccines for the Elderly

FDA will likely decide on the antibody product and some of the vaccines for the elderly by July, or maybe even earlier. The FDA's Committee of Independent Medical Advisors met a few weeks ago to go over the latest data on the two RSV vaccines in older people. They were worried by two side effects that cropped up; one is called acute disseminated encephalomyelitis.